SMS Pharmaceuticals Q1 net profit rises 16% YoY to ₹20.9 crore
SMS Pharmaceuticals posted Q1 FY2027 results for the quarter ended June 30, 2026, with consolidated net profit at ₹20.90 crore, up 16% year on year. Standalone net profit was ₹21.13 crore, also up 16%. Basic and diluted earnings per share were ₹2.23. The board approved the reappointment of Ramesh Babu Potluri as Chairman and Managing Director for five years from October 1, 2026, to September 30, 2031, subject to shareholder approval, and the company holds 99.99% of its subsidiary.